The NZX 50 Index fell to a month low as investors await evidence of earnings growth that would justify a fully priced bourse.
Fisher & Paykel Healthcare fell ahead of reporting tomorrow, while Ryman Healthcare declined after earnings this week met expectations.
The benchmark index fell 26.318 points, or 0.5 percent, to 5108.573. Within the index, 31 stocks fell, nine rose and 10 were unchanged. Turnover was $116 million.
The NZX 50 has advanced 7.9 percent this year, outperforming Australia's S&P/ASX 200 Index's 1 percent gain and Japan's Nikkei 225 14 percent decline. Investors have been drawn to New Zealand's economic growth with forecast gross domestic product growth at an annual pace of 3 percent according to Treasury figures.
F&P Healthcare dropped 1.4 percent to $4.16, and has gained 7.8 percent this year. The breathing apparatus manufacturer is due to report its annual earnings tomorrow. Ryman Healthcare, the retirement operator which reported annual earnings on Monday, slid 1.7 percent to $8.30.